Morning Briefing
Summaries of health policy coverage from major news organizations
Novartis Defends Challenge To Indian Medicines Patent Law
Pharmaceutical company Novartis "has spoken out following criticism about its challenge to India's patent laws, insisting that access to life-saving drugs is not under peril by the move," Pharma Times World News reports. The case, which the Indian Supreme Court is scheduled to hear next month, challenges "Indian patent law, notably Section 3(d), which states that a modification of a known chemical composition is non-patentable," the news service writes.
This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
